It has been about a month since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 3.3% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Synopsys, whose software is ​used by semiconductor firms to design and verify chips, has ​benefited from ⁠surging investment ...